Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis
about
The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancerMeta-analysis of EGFR tyrosine kinase inhibitors compared with chemotherapy as second-line treatment in pretreated advanced non-small cell lung cancer.Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic review.Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer.Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters.EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma.EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression.Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii.Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatmentDACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.Icotinib: activity and clinical application in Chinese patients with lung cancer.Protein kinase inhibitors to treat non-small-cell lung cancer.Pharmacotherapy targeting the EGFR oncogene in NSCLC.Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial.Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.
P2860
Q26740529-B717DA1A-6454-4860-960B-6813EC699C83Q33416457-9D37BE9C-EEC9-4090-9ABA-8205AC9B3B15Q34733257-E32BEC51-C0B1-4E4D-8D3E-BB3DE4B1E37AQ35164824-0ED6042B-5BCB-4DA0-987D-074511604886Q35683412-A50865CA-6A13-4BE4-8879-EE5AFA44CC4EQ35899612-601C191F-B5ED-4DA1-AC78-FB82258D326DQ35992745-B0356646-8CF5-4B52-A2E8-89B5026656A0Q36208467-E2A78971-92BD-49AB-8380-68CF2073AC66Q36224645-0CBC9C6A-11B4-43A7-80B8-7B9334B8BBD9Q36688371-33844B26-A875-4621-91E0-1373B61A8511Q36886148-C0A51412-5F9B-412B-937E-B03FD543F4BEQ37188174-8254C4F7-96B8-4DA0-8DC2-7A302CF46F4BQ38192719-17C4B9C2-FE44-4719-8F44-CCCCE91F4D82Q38205518-9106D8EE-E166-4E16-AAB0-AF86FB78753DQ38248997-270502D5-BF4E-471E-843A-D25D85D75E79Q38930558-F5738202-1097-4C61-AA47-54B907D8BD0FQ39040330-6A1ACFDA-ACB6-4ACE-939A-4A94562136FBQ51054919-E81476D1-2A9B-4E40-9F19-1111E36B4FC2
P2860
Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparison of the efficacy and ...... matic review and meta-analysis
@ast
Comparison of the efficacy and ...... matic review and meta-analysis
@en
Comparison of the efficacy and ...... matic review and meta-analysis
@nl
type
label
Comparison of the efficacy and ...... matic review and meta-analysis
@ast
Comparison of the efficacy and ...... matic review and meta-analysis
@en
Comparison of the efficacy and ...... matic review and meta-analysis
@nl
prefLabel
Comparison of the efficacy and ...... matic review and meta-analysis
@ast
Comparison of the efficacy and ...... matic review and meta-analysis
@en
Comparison of the efficacy and ...... matic review and meta-analysis
@nl
P2093
P31
P3181
P1476
Comparison of the efficacy and ...... matic review and meta-analysis
@en
P2093
Da-Liu Min
Li-Na Tang
Yuan-Jue Sun
P304
P3181
P356
10.7314/APJCP.2012.13.10.5177
P407
P50
P577
2012-01-01T00:00:00Z